Literature DB >> 28288868

Inhibition of Kir4.1 potassium channels by quinacrine.

Leticia G Marmolejo-Murillo1, Iván A Aréchiga-Figueroa2, Meng Cui3, Eloy G Moreno-Galindo1, Ricardo A Navarro-Polanco1, José A Sánchez-Chapula1, Tania Ferrer4, Aldo A Rodríguez-Menchaca5.   

Abstract

Inwardly rectifying potassium (Kir) channels are expressed in many cell types and contribute to a wide range of physiological processes. Particularly, Kir4.1 channels are involved in the astroglial spatial potassium buffering. In this work, we examined the effects of the cationic amphiphilic drug quinacrine on Kir4.1 channels heterologously expressed in HEK293 cells, employing the patch clamp technique. Quinacrine inhibited the currents of Kir4.1 channels in a concentration and voltage dependent manner. In inside-out patches, quinacrine inhibited Kir4.1 channels with an IC50 value of 1.8±0.3μM and with extremely slow blocking and unblocking kinetics. Molecular modeling combined with mutagenesis studies suggested that quinacrine blocks Kir4.1 by plugging the central cavity of the channels, stabilized by the residues E158 and T128. Overall, this study shows that quinacrine blocks Kir4.1 channels, which would be expected to impact the potassium transport in several tissues.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cationic amphiphilic drugs; Kir4.1 channels; Quinacrine

Mesh:

Substances:

Year:  2017        PMID: 28288868      PMCID: PMC5502112          DOI: 10.1016/j.brainres.2017.03.009

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  48 in total

1.  Downregulation of Kir4.1 inward rectifying potassium channel subunits by RNAi impairs potassium transfer and glutamate uptake by cultured cortical astrocytes.

Authors:  Y V Kucheryavykh; L Y Kucheryavykh; C G Nichols; H M Maldonado; K Baksi; A Reichenbach; S N Skatchkov; M J Eaton
Journal:  Glia       Date:  2007-02       Impact factor: 7.452

2.  A possible pharmacological explanation for quinacrine failure to treat prion diseases: pharmacokinetic investigations in a ovine model of scrapie.

Authors:  Véronique Gayrard; Nicole Picard-Hagen; Catherine Viguié; Valerie Laroute; Olivier Andréoletti; Pierre-Louis Toutain
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

Review 3.  The neurobiology of glia in the context of water and ion homeostasis.

Authors:  M Simard; M Nedergaard
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

4.  Mechanisms for Kir channel inhibition by quinacrine: acute pore block of Kir2.x channels and interference in PIP2 interaction with Kir2.x and Kir6.2 channels.

Authors:  Angélica López-Izquierdo; Iván A Aréchiga-Figueroa; Eloy G Moreno-Galindo; Daniela Ponce-Balbuena; Martín Rodríguez-Martínez; Tania Ferrer-Villada; Aldo A Rodríguez-Menchaca; Marcel A G van der Heyden; José A Sánchez-Chapula
Journal:  Pflugers Arch       Date:  2011-07-22       Impact factor: 3.657

5.  Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10.

Authors:  Ute I Scholl; Murim Choi; Tiewen Liu; Vincent T Ramaekers; Martin G Häusler; Joanne Grimmer; Sheldon W Tobe; Anita Farhi; Carol Nelson-Williams; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-16       Impact factor: 11.205

Review 6.  Role and mechanisms of regulation of the basolateral Kir 4.1/Kir 5.1K+ channels in the distal tubules.

Authors:  O Palygin; O Pochynyuk; A Staruschenko
Journal:  Acta Physiol (Oxf)       Date:  2016-05-20       Impact factor: 6.311

7.  Kir4.1/Kir5.1 channel forms the major K+ channel in the basolateral membrane of mouse renal collecting duct principal cells.

Authors:  Sahran Lachheb; Françoise Cluzeaud; Marcelle Bens; Mathieu Genete; Hiroshi Hibino; Stéphane Lourdel; Yoshihisa Kurachi; Alain Vandewalle; Jacques Teulon; Marc Paulais
Journal:  Am J Physiol Renal Physiol       Date:  2008-03-26

Review 8.  Cardiac and renal inward rectifier potassium channel pharmacology: emerging tools for integrative physiology and therapeutics.

Authors:  Daniel R Swale; Sujay V Kharade; Jerod S Denton
Journal:  Curr Opin Pharmacol       Date:  2013-11-26       Impact factor: 5.547

9.  Association between variation in the human KCNJ10 potassium ion channel gene and seizure susceptibility.

Authors:  R J Buono; F W Lohoff; T Sander; M R Sperling; M J O'Connor; D J Dlugos; S G Ryan; G T Golden; H Zhao; T M Scattergood; W H Berrettini; T N Ferraro
Journal:  Epilepsy Res       Date:  2004-02       Impact factor: 3.045

10.  Continuous quinacrine treatment results in the formation of drug-resistant prions.

Authors:  Sina Ghaemmaghami; Misol Ahn; Pierre Lessard; Kurt Giles; Giuseppe Legname; Stephen J DeArmond; Stanley B Prusiner
Journal:  PLoS Pathog       Date:  2009-11-26       Impact factor: 6.823

View more
  4 in total

1.  In vitro and in silico characterization of the inhibition of Kir4.1 channels by aminoglycoside antibiotics.

Authors:  Rita Morán-Zendejas; Mayra Delgado-Ramírez; Jie Xu; Belkis Valdés-Abadía; Iván A Aréchiga-Figueroa; Meng Cui; Aldo A Rodríguez-Menchaca
Journal:  Br J Pharmacol       Date:  2020-08-17       Impact factor: 8.739

2.  VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium Channels.

Authors:  Samantha J McClenahan; Caitlin N Kent; Sujay V Kharade; Elena Isaeva; Jade C Williams; Changho Han; Andrew Terker; Robert Gresham; Roman M Lazarenko; Emily L Days; Ian M Romaine; Joshua A Bauer; Olivier Boutaud; Gary A Sulikowski; Raymond Harris; C David Weaver; Alexander Staruschenko; Craig W Lindsley; Jerod S Denton
Journal:  Mol Pharmacol       Date:  2022-03-03       Impact factor: 4.054

3.  Discovery, Characterization, and Effects on Renal Fluid and Electrolyte Excretion of the Kir4.1 Potassium Channel Pore Blocker, VU0134992.

Authors:  Sujay V Kharade; Haruto Kurata; Aaron M Bender; Anna L Blobaum; Eric E Figueroa; Amanda Duran; Meghan Kramer; Emily Days; Paige Vinson; Daniel Flores; Lisa M Satlin; Jens Meiler; C David Weaver; Craig W Lindsley; Corey R Hopkins; Jerod S Denton
Journal:  Mol Pharmacol       Date:  2018-06-12       Impact factor: 4.436

Review 4.  Inwardly Rectifying Potassium Channel Kir4.1 as a Novel Modulator of BDNF Expression in Astrocytes.

Authors:  Yukihiro Ohno; Masato Kinboshi; Saki Shimizu
Journal:  Int J Mol Sci       Date:  2018-10-24       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.